Symmetry Medical Stock Price, News & Analysis (NYSE:SMA)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Symmetry Medical (NYSE:SMA)

Symmetry Medical logoSymmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.

Receive SMA News and Ratings via Email

Sign-up to receive the latest news and ratings for SMA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Symmetry Medical (NYSE:SMA) Frequently Asked Questions

What is Symmetry Medical's stock symbol?

Symmetry Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SMA."

How were Symmetry Medical's earnings last quarter?

Symmetry Medical Inc. (NYSE:SMA) issued its earnings results on Thursday, October, 30th. The healthcare company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.02. The healthcare company had revenue of $95.90 million for the quarter, compared to the consensus estimate of $98.24 million. The business's revenue for the quarter was up .2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.08 earnings per share. View Symmetry Medical's Earnings History.

Who are some of Symmetry Medical's key competitors?

Who are Symmetry Medical's key executives?

Symmetry Medical's management team includes the folowing people:

  • Thomas W. Barrett, Senior Vice President and Chief Commercial Officer - OEM Solutions
  • Christopher G. Cummins, Senior Vice President, Chief Manufacturing Officer - OEM Solutions (Age 44)
  • Stephen Hinora Jr., Senior Vice President - Quality Assurance/Regulatory Affairs (Age 53)

Has Symmetry Medical been receiving favorable news coverage?

Headlines about SMA stock have trended somewhat positive on Tuesday, Accern Sentiment reports. Accern identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Symmetry Medical earned a coverage optimism score of 0.06 on Accern's scale. They also assigned media coverage about the healthcare company an impact score of 45.95 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Symmetry Medical?

Shares of SMA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Symmetry Medical?

Symmetry Medical's mailing address is 3724 N STATE ROAD 15, WARSAW, IN 46582, United States. The healthcare company can be reached via phone at +1-574-2682252.

MarketBeat Community Rating for Symmetry Medical (SMA)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  79
MarketBeat's community ratings are surveys of what our community members think about Symmetry Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Symmetry Medical (NYSE:SMA) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Symmetry Medical (NYSE:SMA) Earnings History and Estimates Chart

Earnings by Quarter for Symmetry Medical (NYSE:SMA)

Symmetry Medical (NYSE SMA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2014Q3$0.15$0.13$98.24 million$95.90 millionViewListenView Earnings Details
8/4/2014Q2$0.12$0.17$98.38 million$101.30 millionViewListenView Earnings Details
5/1/2014Q1$0.09$0.09$99.10 million$101.30 millionViewListenView Earnings Details
2/20/2014Q413$0.08$0.10$101.50 million$101.20 millionViewListenView Earnings Details
10/31/2013Q313$0.07$0.08$99.05 million$98.00 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.08$0.09$99.01 million$101.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.15$0.06$106.04 million$98.90 millionViewListenView Earnings Details
2/21/2013Q4 2012$0.18$0.17$107.81 million$106.60 millionViewListenView Earnings Details
11/1/2012Q312$0.15$0.18$104.33 million$100.90 millionViewN/AView Earnings Details
8/2/2012$0.13$0.14ViewN/AView Earnings Details
5/3/2012$0.09$0.09ViewN/AView Earnings Details
2/23/2012$0.04$0.01ViewN/AView Earnings Details
11/3/2011$0.12$0.04ViewN/AView Earnings Details
8/4/2011$0.14$0.16ViewN/AView Earnings Details
5/5/2011$0.09$0.09ViewN/AView Earnings Details
2/24/2011$0.15$0.14ViewN/AView Earnings Details
11/4/2010Q3 2010$0.17$0.10ViewN/AView Earnings Details
8/5/2010Q2 2010$0.11$0.14ViewN/AView Earnings Details
5/6/2010Q1 2010$0.05$0.06ViewN/AView Earnings Details
2/25/2010Q4 2009$0.05$0.05ViewN/AView Earnings Details
11/5/2009Q3 2009$0.16$0.15ViewN/AView Earnings Details
8/6/2009Q2 2009$0.21$0.25ViewN/AView Earnings Details
5/7/2009Q1 2009$0.16$0.19ViewN/AView Earnings Details
2/24/2009Q4 2008$0.05$0.13ViewN/AView Earnings Details
11/12/2008Q3 2008$0.20$0.19ViewN/AView Earnings Details
8/6/2008Q2 2008$0.20$0.21ViewN/AView Earnings Details
6/24/2008Q1 2008$0.17$0.15ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Symmetry Medical (NYSE:SMA) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Symmetry Medical (NYSE:SMA)

No dividend announcements for this company have been tracked by

Insider Trades

Symmetry Medical (NYSE SMA) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Symmetry Medical (NYSE:SMA)

Symmetry Medical (NYSE SMA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/3/2014Thomas Joseph SullivanCEOSell35,000$9.69$339,150.00291,206View SEC Filing  
3/5/2014Christopher Gene CumminsSVPSell1,325$10.72$14,204.0048,916View SEC Filing  
2/27/2014Fred HiteCFOSell29,310$10.45$306,289.50228,445View SEC Filing  
(Data available from 1/1/2013 forward)


Symmetry Medical (NYSE SMA) News Headlines


SEC Filings

Symmetry Medical (NYSE:SMA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Symmetry Medical (NYSE:SMA) Income Statement, Balance Sheet and Cash Flow Statement


Symmetry Medical (NYSE SMA) Stock Chart for Tuesday, March, 20, 2018

Loading chart…

This page was last updated on 3/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.